| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.051 | 0.3 |